Skip to content
Fencer Vulns
medium 4.3

CVE-2024-29203 json

TinyMCE Cross-Site Scripting (XSS) vulnerability in handling iframes

published 2024-03-26 2 y ago modified 2026-09-10 1 mo ago also EUVD-2024-0810 , GHSA-438c-3975-5x3f

cvss
4.3
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.7%
EPSS 0.7% chance of exploitation in 30 days, percentile 53%
public exploits
0
none known

Summary

TinyMCE is an open source rich text editor. A cross-site scripting (XSS) vulnerability was discovered in TinyMCE’s content insertion code. This allowed `iframe` elements containing malicious code to execute when inserted into the editor. These `iframe` elements are restricted in their permissions by same-origin browser protections, but could still trigger operations such as downloading of malicious assets. This vulnerability is fixed in 6.8.1.

Patch / fix

  • npm tinymce 6.8.1
  • nuget TinyMCE 6.8.1
  • packagist tinymce/tinymce 6.8.1
  • tiny tinymce 6.8.1

CISA SSVC

Exploitation
none
Automatable
no
Technical impact
partial
Assessed
2 y ago

Exploit prediction

0.71% chance of exploitation in the next 30 days, higher than 53% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by version score vector
CNA 3.1 4.3 CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
GitHub 3.1 4.3 CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
NVD 3.1 6.1 CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Affected packages

ecosystem package affected fixed in
npm tinymce
<6.8.1
6.8.1
nuget TinyMCE
<6.8.1
6.8.1
packagist tinymce/tinymce
<6.8.1
6.8.1

Affected products

  • tinymce tinymce

Classification

Weakness
  • CWE-79 Improper Neutralization of Input During Web Page Generation

References

Sources

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.